3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Pancreatic Neoplasms
8
Multiple Myeloma
6
Neoplasms, Plasma Cell
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Prostatic Neoplasms
3
Leukemia, Myelomonocytic, Chronic
3
Sarcoma
2
Myeloproliferative Disorders
2
Lymphoma
2
Lung Neoplasms
2
Inflammation
2
Frailty
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Adenocarcinoma
2
Ventilator-Induced Lung Injury
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Postoperative Complications
1
Pancreatic Diseases
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Mucositis
1
Interventions
Cisplatin
4
angiotensin I (1-7)
3
Radiotherapy
3
Radiation
3
Injections
3
Water
2
RRx-001
2
Interleukin 1 Receptor Antagonist Protein
2
Drug Therapy
2
Amifostine
2
tempol
1
peppermint oil
1
pegfilgrastim
1
kang-lai-te
1
hydrated silica gel-based toothpaste
1
golotimod
1
glucarpidase
1
fish oil triglycerides
1
calcium phosphate
1
brilacidin
1
anise oil
1
amlexanox
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
Xylitol
1
Vaccinium myrtillus extract
1
Tramadol
1
Therapeutics
1
Surgical Procedures, Operative
1
Sorbic Acid
1
Sodium Bicarbonate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Mucositis
×
Ascorbic Acid
×
Clear all
NCT01898091
2017-03-06
OM
Medical University of South Carolina
Phase 2
Completed
50 enrolled
9 charts